3091 studies found for:    Open Studies | chemotherapy
Show Display Options
Rank Status Study
21 Recruiting The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Postoperative Chemotherapy
22 Recruiting Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   de Novo Myelodysplastic Syndromes;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Intervention: Drug: chemotherapy
23 Recruiting AZD9291 Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Anticancer Treatment
Interventions: Drug: Chemotherapy;   Drug: Cross-over to AZD9291
24 Recruiting Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix
Condition: Cancer of Cervix
Interventions: Drug: NACT;   Procedure: Radical abdominal hysterectomy (class III), BPLND & lower para aortic lymph node sampling;   Drug: Inj.Cisplatin;   Radiation: Concurrent chemo radiotherapy
25 Recruiting Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma
Condition: Signet Ring Cell Gastric Adenocarcinoma
Interventions: Procedure: peri-operative chemotherapy;   Procedure: Surgery first
26 Recruiting A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
Condition: Transitional Cell Carcinoma of Ureter
Interventions: Drug: Chemotherapy;   Other: Surveillance
27 Unknown  A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Endostar;   Drug: Gemcitabine-Cisplatin chemotherapy
28 Recruiting Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Chemotherapy;   Drug: Icotinib+chemotherapy
29 Recruiting Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study
Condition: Nasopharyngeal Carcinoma
Interventions: Device: Chrono-chemotherapy pump:Melodie;   Device: Routine intravenous drip;   Drug: induction chemotherapy;   Drug: cisplatin chrono-chemotherapy;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin routine-chemotherapy
30 Recruiting Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
Condition: Adenocarcinoma Pancreas
Interventions: Procedure: Surgery;   Genetic: Genetic Expression;   Drug: Chemotherapy
31 Recruiting Avastin in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: avastin+chemotherapy of mFOLFOX6 or FOLFIRI;   Drug: chemotherapy of mFOLFOX6 or FOLFIRI
32 Recruiting Intensity-Modulated Scanning Beam Proton Therapy (IMPT) With Simultaneous Integrated Boost (SIB)
Condition: Lung Cancer
Interventions: Radiation: IMPT + SIB + Chemotherapy;   Behavioral: Questionnaire;   Radiation: IMRT + SIB + Chemotherapy
33 Recruiting Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
Conditions: Primary Peritoneal Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma
Intervention: Drug: neoadjuvant chemotherapy
34 Recruiting Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Chemotherapy;   Drug: Herbal therapy
35 Recruiting Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Transarterial chemotherapy;   Drug: Oral chemotherapy
36 Unknown  Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
Condition: Lymphoma, Mantle-Cell
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Fludarabine;   Drug: Interferon-alpha;   Drug: pegylated formula Interferon-alpha 2b;   Procedure: chemotherapy: R-CHOP;   Procedure: chemotherapy: R-FC;   Procedure: Interferon maintenance;   Procedure: Rituximab maintenance
37 Recruiting Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
Condition: Metastatic Colon Cancer
Interventions: Drug: Chemotherapy;   Biological: Chemotherapy plus monoclonal antibody
38 Recruiting TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Conditions: Stage III Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma
Intervention: Drug: TPF induction chemotherapy
39 Unknown  Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Conditions: Gastric Cancer;   Colorectal Cancer;   Chemotherapy
Interventions: Drug: Nutriall;   Drug: LDEPA;   Drug: Placebo;   Drug: HDEPA;   Drug: Chemotherapy
40 Recruiting A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: neoadjuvant chemotherapy plus concurrent chemoradiotherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years